Cigna is ending employee coverage for GLP 1 weight loss drugs like Wegovy and Zepbound starting July 1. The decision highlights growing debates around cost, access, and the future of obesity treatment. #Cigna #GLP1 # Eli Lilly is now offering four doses of Zepbound in self administration vials. The lower cost self pay option targets people on Medicare and those who can no longer access compounded tirzepatide. Click the link Appendicitis Overview Dr Anastasios Christodoulou How Much Wegovy Costs Without Insurance + How to Save Money 12 Common Siberian Husky Health Problems and Concerns A Z Animals